FTC Chair Lina Khan (Michael Brochstein/Sipa USA/Sipa via AP Images)
July 1, 2024 03:42 PM EDTUpdated 03:53 PM
Pharma
Law

FTC in­ves­ti­gates Te­va over patents, dou­bling down on 'bo­gus' Or­ange Book list­ings

Nicole DeFeudis

Editor

The Fed­er­al Trade Com­mis­sion has turned up the pres­sure in its patent probe, of­fi­cial­ly launch­ing a civ­il in­ves­ti­ga­tion in­to a group of Te­va’s drug patents …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Out­look's shares crash as wet AMD drug flunks Phase 3 test

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times